Satoshi Tanida 1, Tsutomu Mizoshita 1, Keiji Ozeki 1, Takahito Katano 1, Mamoru Tanaka 1, Hirotada Nishie 1, Takaya Shimura 1, Yasuyuki Okamoto 1, Eiji Kubota 1, Hiromi Kataoka 1, Takashi Joh 1 , Ther Apher Dial. 2018 Jun;22(3):295-300.
Scientific corner
Combination Therapy With Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Ustekinumab in Patients With Refractory Crohn’s Disease
Thus, combination therapy with intensive granulocyte and monocyte absorptive apheresis plus ustekinumab appeared to represent a safe and effective intervention for inducing clinical remission.
Contact UsFor more information
Contact Us